Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: Implications on mechanism of action

Integrative Cancer Therapies

Volumn 11, Issue 2, 2012, Pages 172-182

  Preethi, Korengath ^a   Ellanghiyil, Sunila ^a   Kuttan, Girija ^a   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

apoptosis; DNA microarray; homeopathy

Indexed keywords

CARCINOSINUM 200C; CASPASE 3; COMPLEMENTARY DNA; COMPLEMENTARY RNA; DNA; HOMEOPATHIC AGENT; HYDRASTIS 200C; PROTEIN BCL 2; PROTEIN P53; RNA; RUTA 200C; THUJA 1M; THUJA 200C; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASCITES TUMOR; ASCITES TUMOR CELL; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HOMEOPATHY; HYDRASTIS; IMMUNOHISTOCHEMISTRY; INDIA; LYMPHOMA; MEDICINAL PLANT; MICROARRAY ANALYSIS; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUTA GRAVEOLENS; SOLID TUMOR; THUJA; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION; HOMEOPATHY; HYDRASTIS; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT PREPARATIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RUTA; THUJA; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862010364     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735411400310     Document Type: Article

References (41)

1. Attarwala H, Bathija D, Akhil A, Philip B, Mathew A, Ahmed KK. Homeopathy - the science of holistic healing: an overview. Pharmacog Mag. 2006;5:7-13.
2. Rosser C. Homeopathy in cancer care: part I. An introduction to "like curing like." Clin J Oncol Nurs. 2004;8:24-26.
3. Jonas WB, Linde K, Ramirez G. Homeopathy and rheumatic disease. Rheum Dis Clin North Am. 2000;26:117-123. (Pubitemid 30091727)
4. Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309:86-89.
5. Pathak S, Multani AS, Banerji P, Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol. 2003;23:975-982.
6. Banerji P, Banerji P. Intracranial cysticercosis: an effective treatment with alternative medicines. In Vivo. 2001;15:181-184. (Pubitemid 32328193)
7. Sunila ES, Kuttan G, Preethi KC, Kuttan R. Effect of homeopathic medicines on transplanted tumors in mice. Asian Pac J Cancer Prev. 2007;8:24-26.
8. Harikumar KB, Sunila ES, Kuttan G, Preethi KC, Venugopal N, Kuttan R. Inhibition of chemically induced carcinogenesis by drugs used in homeopathic medicine. Asian Pac J Cancer Prev. 2007;8:98-102.
9. Biswas SJ, Khuda-Bukhsh AR. Evaluation of protective potentials of a potentized homeopathic drug Chelidonium majus during azo dye induced hepatocarcinogenesis in mice. Indian J Exp Biol. 2004;42:698-714. (Pubitemid 38889462)
10. Biswas SJ, Pathak S, Khuda-Bukhsh AR. Efficacy of a potentized homeopathic drug, Carcinosin-200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p-DAB induced hepatocarcinogenesis in mice. J Altern Complement Med. 2005;11:839-854. (Pubitemid 41739356)
11. Banerjee P, Bhattacharyya SS, Pathak S, Boujedaini N, Belon P, Khuda-Bukhsh AR. Evidences of protective potentials of microdoses of ultra-high diluted arsenic trioxide in mice receiving repeated injections of arsenic trioxide [published online ahead of print February 25, 2009]. Evid Based Complement Alternat Med. doi:10.1093/ecam/nen090.
12. Jonas WB, Gaddipati JP, Rajeshkumar NV, et al. Can homeopathic treatment slow prostate cancer growth? Integr Cancer Ther. 2006;5:343-349. (Pubitemid 44721990)
13. MacLaughlin BW, Gutsmuths B, Pretner E, et al. Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther. 2006;5: 362-372. (Pubitemid 44721993)
14. Sunila ES, Kuttan R, Preethi KC, Kuttan G. Action of dynamized medicines in cell culture. Evid Based Complement Alternat Med. 2009;6:257-263.
15. Thangapazham RL, Gaddipati JP, Rajeshkumar NV, et al. Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther. 2006;5:356-361. (Pubitemid 44721992)
16. Porozov S, Cahalon L, Weisesr M, Branski D, Lider O, Oberbaum M. Inhibition of IL-1 beta and TNF-alpha secretion from resting and activated human immunocytes by homeopathic medication Traumeel S. Clin Dev Immunol. 2004;11: 143-149. (Pubitemid 38955071)
17. Ramachandran C, Raveendran Nair PK, Clèment RT, Melnick SJ. Investigation of cytokine expression in human leukocyte cultures with two immune-modulatory homeopathic preparations. J Altern Complement Med. 2007;13:403-407. (Pubitemid 46802344)
18. Committee on Pharmacopoeia of the American Institute of Homeopathy. The Homeopathic Pharmacopoeia of the United States. 6th ed. Boston, MA: Otis Clapp; 1954.
19. Klebe RJ, Grant GM, Grant AM, Garcia MA, Giambernardi TA, Taylor GP. RT-PCR without RNA isolation. Biotechniques. 1996;21:1094-1100. (Pubitemid 26422017)
20. Preethi KC, Kuttan R. Antitumor activity of Ruta graveolens extract. Asian Pac J Cancer Prev. 2006;7:439-443.
21. Gong SM, Hay S, Marshall KR, Munro AW, Scrutton NS. DNA binding suppresses human AIF-M2 activity and provides a connection between redox chemistry, reactive oxygen species, and apoptosis. J Biol Chem. 2007;282:30331-30340. (Pubitemid 350035262)
22. Romero I, Páez A, Ferruelo A, Luján M, Berenguer A. Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells. BJU Int. 2002;89:950-954. (Pubitemid 34535434)
23. Dedoussis GV, Kaliora AC, Andrikopoulos NK. Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line. Cell Biol Int. 2005;29:884-889. (Pubitemid 41654791)
24. Frenkel M, Mishra BM, Sen S, et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol. 2010;36:395-402.
25. Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase upregulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem. 2007;282:8069-8078. (Pubitemid 47093605)
26. Brenner C, Cadiou H, Vieira HL. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene. 2000;19:329-336. (Pubitemid 30077332)
27. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol. 2000;12:414-419. (Pubitemid 30453590)
28. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441-446.
29. Daugas E, Nochy D, Ravagnan L, et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 2000;476:118-123. (Pubitemid 30410801)
30. Eigo S, Hiroaki K, Kazunari T. Identification of a caspase 3-independent role of pro-apoptotic factor Bak in TNF-alphainduced apoptosis. FEBS Lett. 2002;528:63-69.
31. Loeffler M, Daugas E, Susin SA, et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J. 2001;15:758-767. (Pubitemid 32245994)
32. Wahbe KR, Biliran H, Luo X, et al. Anoikis effector Bit1 negatively regulates Erk activity. Proc Natl Acad Sci U S A. 2008;105:1528-1532. (Pubitemid 351346548)
33. D'Orazi G, Cecchinelli B, Bruno T, et al. Homeodomaininteracting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol. 2002;4:11-19.
34. Ramjaun AR, Tomlinson S, Eddaoudi A, Downward J. Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis. Oncogene. 2007;26:970-981.
35. Hur GM, Kim YS, Won M, Choksi S, Liu ZG. The death domain kinase RIP has an important role in DNA damageinduced, p53-independent cell death. J Biol Chem. 2006;281: 25011-25017. (Pubitemid 44401889)
36. Takahashi Y, Karbowski M, Yamaguchi H, et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol. 2005;25:9369-9382. (Pubitemid 41507838)
37. Bellavite P, Conforti A, Ortolani R. Immunology and homeopathy. Experimental studies on animal models. Evid Based Complement Alternat Med. 2006;3:171-186.
38. Bellavite P, Conforti A, Pontarollo F, Ortolani R. Immunology and homeopathy.2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med. 2006;3:13-24.
39. de Oliveira CC, de Oliveira SM, Goes VM, Probst CM, Krieger MA, Buchi DF. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem. 2008;104:1364-1377.
40. Khuda-Bukhsh AR. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem. 2003;253:339-345. (Pubitemid 37321741)
41. Khuda-Bukhsh AR. Potentized homeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med. 1997;5:43-46.